Zhengye Biotechnology Holding Limited (ZYBT)

ZYBT Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-69.78	11.31	31.46	46.74	38.96
Depreciation & Amortization	25.96	24.16	23.91	18.8	16.01
Loss (Gain) From Sale of Assets	-	0.17	0.19	-	-0.05
Asset Writedown & Restructuring Costs	-	-	-	-	0.08
Loss (Gain) From Sale of Investments	-0.13	-0.21	-	-	-
Provision & Write-off of Bad Debts	1.44	-1.78	-3.71	9.74	1.93
Other Operating Activities	11.02	8.37	16.62	8.66	8.59
Change in Accounts Receivable	39.71	16.35	31.04	-24.72	-28.5
Change in Inventory	8.23	-13.56	-13.52	-13.04	-12.6
Change in Accounts Payable	-3.36	-0.4	-35.61	-9.67	17.63
Change in Unearned Revenue	1.27	-0.4	-0.72	0.32	1.4
Change in Income Taxes	0.28	-0.23	-7.7	3.19	0.8
Change in Other Net Operating Assets	-1.3	-2.73	6.23	-22.67	-12.44
Operating Cash Flow	13.33	41.05	48.18	17.34	31.81
Operating Cash Flow Growth	-67.52%	-14.81%	177.96%	-45.50%	-

Investing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-1.01	-13.59	-7.4	-27.33	-19.06
Sale of Property, Plant & Equipment	-	0.11	1.06	-	0.13
Sale (Purchase) of Intangibles	-11.62	-14.19	-4.2	-	-7.34
Investment in Securities	-	-	-1.22	-	-
Investing Cash Flow	-12.63	-27.67	-11.77	-27.33	-26.27

Financing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	0.15	-	-	-
Long-Term Debt Issued	70.47	90.12	79.86	99.85	30
Total Debt Issued	70.47	90.27	79.86	99.85	30
Short-Term Debt Repaid	-0.15	-	-	-	-
Long-Term Debt Repaid	-82.56	-92.86	-54.89	-64.97	-22
Total Debt Repaid	-82.71	-92.86	-54.89	-64.97	-22
Net Debt Issued (Repaid)	-12.24	-2.59	24.97	34.88	8
Issuance of Common Stock	44.55	-	-	-	-
Common Dividends Paid	-	-16.02	-39.45	-21.43	-11.05
Other Financing Activities	-	-3.51	-4.5	-	-
Financing Cash Flow	32.31	-22.13	-18.98	13.46	-3.05

Net Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-1.29	0.17	-	-	-
Net Cash Flow	31.73	-8.58	17.44	3.46	2.49

Free Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	12.33	27.46	40.79	-9.99	12.75
Free Cash Flow Growth	-55.12%	-32.68%	-	-	-
Free Cash Flow Margin	10.59%	14.74%	19.27%	-3.84%	5.96%
Free Cash Flow Per Share	0.26	0.60	0.89	-0.22	0.28
Levered Free Cash Flow	39.58	3.31	42.32	-13.35	-
Unlevered Free Cash Flow	41.7	5.83	45.08	-11.57	-

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	3.36	3.99	4.42	2.84	1.05
Cash Income Tax Paid	-	0.12	10.49	8.48	6.99
Change in Working Capital	44.83	-0.98	-20.28	-66.6	-33.71

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Apr 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 17, 2026

Data Sources Report a data error